Attach Importance to System Construction and Create Characteristic Operation
Release time:
2020-08-14
Attaches great importance to system construction and creates characteristic operation
Pharmaceutical Company 2017 Advanced Enterprise Peak Pharmacy
2017 is a mixed blessing for large pharmacies. The good news is that the national policy tends to be favorable, and the bad news is that a large number of competitors are swarming under the influence of good news. 2017 Jinhua City opened nearly 40 new stores, added 40 health insurance stores, added 2 slow insurance stores, and many policies could not be implemented due to local factors. In the ever-changing environment, large pharmacies strengthen internal management, practice internal skills, expand ideas and seek cooperation externally, and promote work from three aspects: system construction, sales model innovation, and team building.
1. attaches importance to system construction and promotes standardized and refined management of functional departments and offices.
2017 On the basis of investigation and research, large pharmacies formulated and adjusted a number of rules and regulations, strengthened process management, made the management of functional departments more targeted and effective, and better provided service guarantee for store operation. Formulate measures for the management of commodity flow, change from manual to information management, clarify charging standards, improve work efficiency and eliminate loopholes; according to the actual situation, the original contract process was adjusted, the contract countersigning system was implemented, the special person was responsible for the payment, the responsibilities were clear, and the level of control was checked, which improved the rebate ability. In terms of personnel management, a series of assessment systems have been established around how to improve the enthusiasm of employees, including the assessment system of warehouses and the incentive system of shop assistants, which have achieved good results. In view of the low professional skills of some post personnel and the lack of active learning motivation, the pharmacy has changed the traditional training mode, introduced a professional short video training and learning platform, combined online training with classroom teaching, formulated a training points assessment mechanism, and made full use of employees' free time to help each other, aiming to cultivate a team with high professional standards and reserve talents for the future development of the pharmacy.
2. develop ideas and create characteristic management.
actively develop out-of-hospital business and further strengthen cooperation with people's hospitals; Improve the standardized management of DTP pharmacy and add a number of DTP drugs. With the in-depth development of the medical system reform, hospitals are limited by the proportion of drugs and some prescription drugs flow to the retail market. Large pharmacies actively communicate with hospitals and manufacturers and vigorously introduce special drugs and new drug varieties. In 2017 , out-of-hospital sales (including DTP varieties) reached 2000 ,000.
Build Jinhua's first chronic disease health management center, establish a chronic disease professional service team, and enhance the brand of Jianfeng Pharmacy with "professional" and "characteristic service. Regularly carry out community activities, improve customer stickiness with services, and cultivate a group of high-quality loyal customers. Take Shizhen Pavilion as an example. Since the service was launched, membership has increased by 95.7% , and chronic disease sales have increased by 55.5% year on year.
Carry out diversified marketing to promote store sales growth. In order to improve the brand influence, the big pharmacy takes public welfare as the carrier to carry out diversified health promotion activities, and jointly organizes the "health through train" activity with China Health Promotion Association. Carry out health activities with Qianjiang TV Channel to care for waist patients. Carry out healthy diet education activities on "United Nations Diabetes Day"; In Jinhua TV Station and brain platinum manufacturers to carry out preferential month activities for chronic diseases, etc. The development of various public welfare activities not only brings passenger flow to the store, but also improves the reputation of the enterprise.
3. safety is the most important thing to ensure the normal operation order.
strictly follows GSP management, regularly inspects subordinate stores, implements responsibility assessment at various levels, and "zero tolerance" for irregular operations. For example, in the first half of the year, the Quality Department found that Tangxi Pharmacy had violated regulations in its routine inspection and finally recovered its management rights. Because of the standardized management, large pharmacies successfully passed the examination and approval of chronic disease designated pharmacies and medical insurance designated pharmacies in August, and 11 all stores passed the on-site examination of designated retail pharmacies by the medical insurance bureau with high scores.
Attaches great importance to safety education for employees, and conducts safety education for employees through various forms such as safety drills, lectures, meetings, and safety inspections to enhance employees' awareness of safety in production. 2017 No case of illegal operation of large pharmacies was punished, effectively ensuring the implementation and completion of business objectives. The achievements of
belong to the past, and there is a long way to go in the future. in the face of the new situation, new opportunities and new challenges, all the staff of the pharmacy will further forge ahead and strive for better results in the new year. (According to the speech made by He Songqin, general manager of Jianfeng Pharmacy, at the summary and commendation meeting of the pharmaceutical company)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31